Page 126 - NobleCon19revC2_Neat

Health Care
Date November 21, 2023 Health Care
52wk High $4.53
52wk Low $1.95 Lisata Therapeutics, Inc. LSTA $2.24
110 Allen Road
Basking Ridge, NJ 07920

(USD - in millions) www.lisata.com
Market Cap 18.6
Enterprise (35.7)
Basic Shares Out. 8.14 COMPANY OVERVIEW
Float 6.80
Institutional Holdings 8.59% Detailed Analysis:Channelchek.com
Short Interest 0.05
Avg. 90-Day Volume 0.02 Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company
dedicated to the discovery, development, and commercialization of
innovative therapies for the treatment of advanced solid tumors and
other major diseases.
EPS Data
2021 2022 2023
CQ1 (2.85) (1.05) (0.77)
CQ2 (1.50) (1.65) (0.50)

CQ3 (1.80) (1.47) (0.65)
CQ4 (1.65) (0.76) (0.86)
CY (7.50) (4.60) (2.91) Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 6.51
ROE (ttm) -34.49
Debt-to-Total Cap. (mrq) 0.65
Fiscal Year End 31-Dec
110 Allen Roa Basking RidgeNJ 07920

Key Executives
CEO: Mazzo, David
CFO: Nisco, James
COO: Imam, Tariq
IR: Menditto, John
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
rleboyer@noblelsp.com available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures